Snake venom contains peptides with dual antimicrobial and anticancer properties that could become next-generation drugs against superbugs and tumors.
Dual-function peptidesSnake venom peptides can target both drug-resistant bacteria and cancer cells
What the researchers found
Snake venom-derived peptides demonstrate validated antimicrobial and anticancer activities, with several compounds showing dual functionality against both drug-resistant bacteria and tumor cells through membrane-disrupting mechanisms.
Why it matters
With antibiotic resistance rising and cancer treatment options still limited, snake venom peptides offer a largely untapped source of compounds that could address both crises simultaneously.
The numbers in context
Multiple SV peptides with validated AMP and ACP activity; existing SV-based cardiovascular drugs on market
How the study worked
Comprehensive literature review analyzing experimentally validated and computationally predicted antimicrobial and anticancer peptides derived from snake venoms, covering in vitro and in vivo studies.
Who was studied
Not applicable (review of preclinical research)
What this study cannot tell us
As a review, no new experimental data is presented. Many cataloged peptides remain at early discovery stages. Translation from venom compounds to clinical drugs faces challenges including stability, toxicity, and manufacturing scale.
How to read the evidence
Moderate — comprehensive review of existing literature but no new experimental data; many compounds at early research stages.
When this study was published
Published in 2020, this review captures the field up to that point; rapid advances in peptide engineering may have expanded the pipeline since.
The bigger picture
This work sits at the intersection of natural product drug discovery, antimicrobial resistance, and oncology — three areas where new therapeutic approaches are urgently needed. Venom-derived peptides represent a nature-inspired strategy that complements synthetic drug design.
Questions still open
- Which snake venom peptides are closest to clinical trials for antimicrobial or anticancer use?
- Can dual-function venom peptides be engineered to maximize both antimicrobial and anticancer activity?
- How do venom peptide production costs compare to conventional antibiotics and chemotherapeutics?
Common questions
Are snake venom peptides safe to use as drugs?
How do venom peptides kill bacteria and cancer cells?
Read the original research
Hitchhiking with Nature: Snake Venom Peptides to Fight Cancer and Superbugs.
Toxins, 12(4)
Citation
Pérez-Peinado, Clara; Defaus, Sira; Andreu, David. (2020). Hitchhiking with Nature: Snake Venom Peptides to Fight Cancer and Superbugs.. Toxins, 12(4). https://doi.org/10.3390/toxins12040255